1456
J.-J. Tang et al. / Free Radical Biology & Medicine 50 (2011) 1447–1457
induction of p53 and downregulation of mitochondrial superoxide dismutase.
References
Toxicol. In Vitro 22:1361–1370; 2008.
[1] Gullett, N. P.; Ruhul Amin, A. R. M.; Bayraktar, S.; Pezzuto, J. M.; Shin, D. M.; Khuri, F. R.;
Aggarwal, B. B.; Surh, Y. -J.; Kucuk, O. Cancer prevention with natural compounds.
Semin. Oncol. 37:258–281; 2010.
[2] Khan, N.; Afaq, F.; Mukhtar, H. Cancer chemoprevention through dietary
antioxidants: progress and promise. Antioxid. Redox Signaling 10:475–510; 2008.
[3] Pan, M. -H.; Ho, C. -T. Chemopreventive effects of natural dietary compounds on
cancer development. Chem. Soc. Rev. 37:2558–2574; 2008.
[32] Balan, K. V.; Wang, Y.; Chen, S. W.; Chen, J. -C.; Zheng, L. -F.; Yang, L.; Liu, Z. -L.;
Pantazis, P.; Wyche, J. -H.; Han, Z. Proteasome-independent down-regulation of
estrogen receptor-α (ERα) in breast cancer cells treated with 4,4′-dihydroxy-
trans-stilbene. Biochem. Pharmacol. 72:573–581; 2006.
[33] Roberti, M.; Pizzirani, D.; Recanatini, M.; Simoni, D.; Grimaudo, S.; Cristina, A. D.;
Abbadessa, V.; Gebbia, N.; Tolomeo, M. Identification of a terphenyl derivative
that blocks the cell cycle in the G0–G1 phase and induces differentiation in
leukemia cells. J. Med. Chem. 49:3012–3018; 2006.
[4] Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and
signalling pathways. Mol. Nutr. Food Res. 52:507–526; 2008.
[5] Francy-Guilford, J.; Pezzuto, J. M. Mechanisms of cancer chemopreventive agents:
a perspective. Planta Med. 74:1644–1650; 2008.
[34] Gosslau, A.; Chen, M.; Ho, C. T.; Chen, K. Y. A methoxy derivative of resveratrol
analogue selectively induced activation of the mitochondrial apoptotic pathway
in transformed fibroblasts. Br. J. Cancer 92:513–521; 2005.
[6] Aggarwal, B. B.; Shishodia, S. Molecular targets of dietary agents for prevention
and therapy of cancer. Biochem. Pharmacol. 71:1397–1421; 2006.
[7] Surh, Y. -J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer
3:768–780; 2003.
[35] Wang, Y.; Wang, B.; Cheng, J.; Yang, L.; Liu, Z. -L.; Balan, K.; Pantazis, P.; Wyche, J.
H.; Han, Z. FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the
resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene. Biochem. Pharmacol. 69:
249–254; 2005.
[8] Athar, M.; Back, J. H.; Kopelovich, L.; Bickers, D. R.; Kim, A. L. Multiple molecular
targets of resveratrol: anti-carcinogenic mechanisms. Arch. Biochem. Biophys. 486:
95–102; 2009.
[36] Lion, C. J.; Matthews, C. S.; Stevens, M. F. G.; Westwell, A. D. Synthesis, antitumor
evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes. J. Med.
Chem. 48:1292–1295; 2005.
[9] Shakibaei, M.; Harikumar, K. B.; Aggarwal, B. B. Resveratrol addiction: to die or not
to die. Mol. Nutr. Food Res. 53:115–128; 2009.
[10] Pervaiz, S.; Holme, A. L. Resveratrol: its biologic targets and functional activity.
Antioxid. Redox Signaling 11:2851–2857; 2009.
[11] Saiko, P.; Szakmary, A.; Jaeger, W.; Szekeres, T. Resveratrol and its analogs:
defense against cancer, coronary disease and neurodegenerative maladies or just
a fad? Mutat. Res. 658:68–94; 2008.
[12] Pezzuto, J. M. Grapes and human health: a perspective. J. Agric. Food Chem. 56:
6777–6784; 2008.
[13] Kundu, J. K.; Surh, Y. -J. Cancer chemopreventive and therapeutic potential of
resveratrol: mechanistic perspectives. Cancer Lett. 269:243–261; 2008.
[14] Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence.
Nat. Rev. Drug Discovery 5:493–506; 2006.
[15] Signorelli, P.; Ghidoni, R. Resveratrol as an anticancer nutrient: molecular basis,
open questions and promises. J. Nutr. Biochem. 16:449–466; 2005.
[16] Ulrich, S.; Wolter, F.; Stein, J. M. Molecular mechanisms of the chemopreventive
effects of resveratrol and its analogs in carcinogenesis. Mol. Nutr. Food Res. 49:
452–461; 2005.
[37] Sale, S.; Verschoyle, R. D.; Boocock, D.; Jones, D. J. L.; Wilsher, N.; Ruparelia, K. C.;
Potter, G. A.; Farmer, P. B.; Steward, W. P.; Gescher, A. J. Pharmacokinetics in mice
and growth-inhibitory properties of the putative cancer chemopreventive agent
resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br. J.
Cancer 90:736–744; 2004.
[38] Roberti, M.; Pizzirani, D.; Simoni, D.; Rondanin, R.; Baruchello, R.; Bonora, C.; Buscemi,
F.; Grimaudo, S.; Tolomeo, M. Synthesis and biological evaluation of resveratrol and
analogues as apoptosis-inducing agents. J. Med. Chem. 46:3546–3554; 2003.
[39] Lu, J.; Ho, C. -T.; Ghai, G.; Chen, K. Y. Resveratrol analog, 3,4,5,4′-tetrahydrox-
ystilbene, differentially induces pro-apoptotic p53/Bax gene expression and
inhibits the growth of transformed cells but not their normal counterparts.
Carcinogenesis 22:321–328; 2001.
[40] Klaunig, J. E.; Kamendulis, L. M. The role of oxidative stress in carcinogenesis.
Annu. Rev. Pharmacol. Toxicol. 44:239–267; 2004.
[41] Hussain, S. P.; Hofseth, L. J.; Harris, C. C. Radical causes of cancer. Nat. Rev. Cancer 3:
276–285; 2003.
[42] Queiroz, A. N.; Gomes, B. A. Q.; Moraes, J. W. M.; Borges, R. S. A theoretical antioxidant
pharmacophore for resveratrol. Eur. J. Med. Chem. 44:1644–1649; 2009.
[43] Fukuhara, K.; Nakanishi, I.; Matsuoka, A.; Matsumura, T.; Honda, S.; Hayashi, M.;
Ozawa, T.; Miyata, N.; Saito, S.; Ikota, N.; Okuda, H. Effect of methyl substitution on
the antioxidative property and genotoxicity of resveratrol. Chem. Res. Toxicol. 21:
282–287; 2008.
[44] Fabris, S.; Momo, F.; Ravagnan, G.; Stevanato, R. Antioxidant properties of
resveratrol and piceid on lipid peroxidation in micelles and monolamellar
liposomes. Biophys. Chem. 135:76–83; 2008.
[17] Delmas, D.; Lancon, A.; Colin, D.; Jannin, B.; Latruffe, N. Resveratrol as
a
chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug
Targets 7:423–442; 2006.
[18] Aggarwal, B. B.; Bhardwaj, A.; Aggarwal, R. S.; Seeram, N. P.; Shishodia, S.; Takada,
Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical
studies. Anticancer Res. 24:2783–2840; 2004.
[19] Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H.
H. S.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; Pezzuto, J. M.
Cancer chemopreventive activity of resveratrol, a natural product derived from
grapes. Science 275:218–220; 1997.
[20] Lee, S. K.; Zhang, W.; Sanderson, B. J. S. Selective growth inhibition of human
leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and
apoptosis induction. J. Agric. Food Chem. 56:7572–7577; 2008.
[45] Murias, M.; Jäger, W.; Handler, N.; Erker, T.; Horvath, Z.; Szekeres, T.; Nohl, H.; Gille, L.
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues:
structure–activity relationship. Biochem. Pharmacol. 69:903–912; 2005.
[46] Amorati, R.; Lucarini, M.; Mugnaini, V.; Pedulli, G. F.; Roberti, M.; Pizzirani, D.
Antioxidant activity of hydroxystilbene derivatives in homogeneous solution.
J. Org. Chem. 69:7101–7107; 2004.
[21] Dörrie, J.; Gerauer, H.; Wachter, Y.; Zunino, S. J. Resveratrol induces extensive
apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in
acute lymphoblastic leukemia cells. Cancer Res. 61:4731–4739; 2001.
[22] Clément, M. -V.; Hirpara, J. L.; Chawdhury, S. H.; Pervaiz, S. Chemopreventive
agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-
dependent apoptosis in human tumor cells. Blood 92:996–1002; 1998.
[23] Wenzel, E.; Somoza, V. Metabolism and bioavailability of trans-resveratrol. Mol.
Nutr. Food Res. 49:472–481; 2005.
[24] Goldberg, D. M.; Yan, J.; Soleas, G. J. Absorption of three wine-related polyphenols
in three different matrices by healthy subjects. Clin. Biochem. 36:79–87; 2003.
[25] Jeong, S. H.; Jo, W. S.; Song, S.; Suh, H.; Seol, S. -Y.;Leem, S. -H.; Kwon, T. K.; Yoo, Y. H. A
novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in
human leukemic U937 cells. Biochem. Pharmacol. 77:1337–1347; 2009.
[47] Caruso, F.; Tanski, J.; Villegas-Estrada, A.; Rossi, M. Structural basis for antioxidant
activity of trans-resveratrol: ab initio calculations and crystal and molecular
structure. J. Agric. Food Chem. 52:7279–7285; 2004.
[48] Fang, J. -G.; Lu, M.; Chen, Z. -H.; Zhu, H. -H.; Li, Y.; Yang, L.; Wu, L. -M.; Liu, Z. -L.
Antioxidant effects of resveratrol and its analogues against the free-radical-
induced peroxidation of linoleic acid in micelles. Chem. Eur. J. 8:4191–4198; 2002.
[49] Stojanović, S.; Brede, O. Elementary reactions of the antioxidant action of trans-
stilbene derivatives: resveratrol, pinosylvin and 4-hydroxystilbene. Phys. Chem.
Chem. Phys. 4:757–764; 2002.
[50] Stivala, L. A.; Savio, M.; Carafoli, F.; Perucca, P.; Bianchi, L.; Maga, G.; Forti, L.;
Pagnoni, U. M.; Albini, A.; Prosperi, E.; Vannini, V. Specific structural determinants
are responsible for the antioxidant activity and the cell cycle effects of resveratrol.
J. Biol. Chem. 276:22586–22594; 2001.
[26] Fulda, S. Resveratrol and derivatives for the prevention and treatment of cancer.
[51] Stojanović, S.; Sprinz, H.; Brede, O. Efficiency and mechanism of the antioxidant
action of trans-resveratrol and its analogues in the radical liposome oxidation.
Arch. Biochem. Biophys. 391:79–89; 2001.
[52] Wang, M.; Jin, Y.; Ho, C. -T. Evaluation of resveratrol derivatives as potential
antioxidants and identification of a reaction product of resveratrol and 2,2-
diphenyl-1-picryhydrazyl radical. J. Agric. Food Chem. 47:3974–3977; 1999.
[53] Mikulski, D.; Górniak, R.; Molski, M. A theoretical study of the structure–radical
scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase
and water environment. Eur. J. Med. Chem. 45:1015–1027; 2010.
[54] Shang, Y. -J.; Qian, Y. -P.; Liu, X. -D.; Dai, F.; Shang, X. -L.; Jia, W. -Q.; Liu, Q.; Fang, J. -G.;
Zhou, B. Radical-scavenging activity and mechanism of resveratrol-oriented analogues:
influence of the solvent, radical, and substitution. J. Org. Chem. 74:5025–5031; 2009.
[55] Fang, J. -G.; Zhou, B. Structure–activity relationship and mechanism of the
tocopherol-regenerating activity of resveratrol and its analogues. J. Agric. Food
Chem. 56:11458–11463; 2008.
[56] Zheng, L. -F.; Wei, Q. -Y.; Cai, Y. -J.; Fang, J. -G.; Zhou, B.; Yang, L.; Liu, Z. -L. DNA
damage induced by resveratrol and its synthetic analogues in the presence of Cu
(II) ions: mechanism and structure–activity relationship. Free Radic. Biol. Med. 41:
1807–1816; 2006.
Drug Discov. Today 15:757–765 and references therein; 2010.
[27] Pan, M. -H.; Lin, C. -L.; Tsai, J. -H.; Ho, C. -T.; Chen, W. -J. 3,5,3′,4′,5′-
Pentamethoxystilbene (MR-5), a synthetically methoxylated analogue of resvera-
trol, inhibits growth and induces G1 cell cycle arrest of human breast carcinoma
MCF-7 cells. J. Agric. Food Chem. 58:226–234; 2010.
[28] Madlener, S.; Saiko, P.; Vonach, C.; Viola, K.; Huttary, N.; Stark, N.; Popescu, R.;
Gridling, M.; Vo, N. T. -P.; Herbacek, I.; Davidovits, A.; Giessrigl, B.; Venkateswarlu,
S.; Geleff, S.; Jäger, W.; Grusch, M.; Kerjaschki, D.; Mikulits, W.; Golakoti, T.;
Fritzer-Szekeres, M.; Szekeres, T.; Krupitza, G. Multifactorial anticancer effects of
digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of
lymphendothelial gap formation in vitro. Br. J. Cancer 102:1361–1370; 2010.
[29] Savio, M.; Coppa, T.; Bianchi, L.; Vannini, V.; Maga, G.; Forti, L.; Cazzalini, O.; Lazzè, M.
C.; Perucca, P.; Prosperi, E.; Stivala, L. A. The resveratrol analogue 4,4′-dihydroxy-
trans-stilbene inhibits cell proliferation with higher efficiency but different
mechanism from resveratrol. Int. J. Biochem. Cell Biol. 41:2493–2502; 2009.
[30] Pettit, G. R.; Melody, N.; Thornhill, A.; Knight, J. C.; Groy, T. L.; Herald, C. L.
Antineoplastic agents. 579. Synthesis and cancercellgrowth evaluation of E-stilstatin
3: a resveratrol structural modification. J. Nat. Prod. 72:1637–1642; 2009.
[31] Murias, M.; Luczak, M. W.; Niepsuj, A.; Krajka-Kuzniak, V.; Zielinska-Przyjemska,
M.; Jagodzinski, P. P.; Jäger, W.; Szekeres, T.; Jodynis-Liebert, J. Cytotoxic activity
of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by
[57] Fan, G. -J.; Liu, X. -D.; Qian, Y. -P.; Shang, Y. -J.; Li, X. -Z.; Dai, F.; Fang, J. -G.; Jin, X. -L.;
Zhou, B. 4,4′-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced
antioxidant activity and cytotoxicity. Bioorg. Med. Chem. 17:2360–2365; 2009.